Takeda
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.
Business & Industry
- Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
- Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
- Bayer Consumer Health leaders propose new principles for science-led self-care
- GSK signs agreement to support pandemic preparedness in Europe
- Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
Research & Development
- Scientists create long-acting injectable drug delivery system for tuberculosis
- Treating cancer by sticking cells in place
- Vitamin K prevents cell death: a new function for a long-known molecule
- Disparities in United States COVID-19 vaccine distribution
- New needle-free nasal vaccine shows promise for COVID-19
- Scientists develop new biomimetic formulation for treating glioblastoma
- SARS-CoV-2 hijacks nanotubes between neurons to infect them
Conferences & Events
- New approach to treatment of deadly kidney cancer
- SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
- Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
- SMi's 22nd Annual Pain Therapeutics Conference
- SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
- SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
- SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
- FDA approves first systemic treatment for alopecia areata
- FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
- FDA limits use of Janssen COVID-19 vaccine to certain individuals
- EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
- FDA approves first generic of Symbicort to treat asthma and COPD